Received Jun 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Suspected vaccination failure; Shingles; stressed; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) solution for injection for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and stress (Verbatim: stressed). The outcome of the vaccination failure, shingles and stress were not reported. It was unknown if the reporter considered the vaccination failure, shingles and stress to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 09-JUN-2026 This case was reported by a patient via interactive digital media. The patient was still getting the shingles outbreak when heshe was stressed despite vaccination. This case was considered as vaccination failure as details regarding primary vaccination schedule, time to onset for Shingles and laboratory confirmation regarding Shingles were unknown at the time of reporting. The batch number was not provided, and we are unable to contact the reporter; Sender's Comments: Event Vaccination failure, an unknown time after receiving Shingles vaccine in an unknown aged and unknown gender subject. Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, completion of vaccination schedule and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.